Oncolytic adenoviruses expressing interleukin: a novel antitumour approach.
about
Oncolytic adenovirus expressing IL-23 and p35 elicits IFN-γ- and TNF-α-co-producing T cell-mediated antitumor immunity.Combining conditionally replicating adenovirus-mediated gene therapy with chemotherapy: a novel antitumor approach.Local sustained delivery of oncolytic adenovirus with injectable alginate gel for cancer virotherapy.
P2860
Oncolytic adenoviruses expressing interleukin: a novel antitumour approach.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Oncolytic adenoviruses expressing interleukin: a novel antitumour approach.
@en
Oncolytic adenoviruses expressing interleukin: a novel antitumour approach.
@nl
type
label
Oncolytic adenoviruses expressing interleukin: a novel antitumour approach.
@en
Oncolytic adenoviruses expressing interleukin: a novel antitumour approach.
@nl
prefLabel
Oncolytic adenoviruses expressing interleukin: a novel antitumour approach.
@en
Oncolytic adenoviruses expressing interleukin: a novel antitumour approach.
@nl
P2860
P921
P1476
Oncolytic adenoviruses expressing interleukin: a novel antitumour approach.
@en
P2093
Dong-Sheng Pei
Jun-Nian Zheng
P2860
P304
P356
10.1517/14712598.2010.481668
P407
P577
2010-06-01T00:00:00Z